Therapeutic groups
Gross spend in millions
Therapeutic group | Main indication | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
1 |
Immunosuppressants |
Autoimmune conditions, arthritis, transplant and biologics for cancer |
$280.3 |
$297.3 |
$326.5 |
$311.3 |
2 |
Chemotherapeutic Agents |
Cancer |
$103.9 |
$138.7 |
$150.0 |
$154.2 |
3 |
Diabetes |
Diabetes |
$75.8 |
$91.8 |
$123.7 |
$146.6 |
4 |
Vaccinations |
Vaccine preventable diseases |
$117.4 |
$115.9 |
$111.9 |
$128.8 |
5 |
Antithrombotic Agents |
Stopping blood clots |
$76.0 |
$86.2 |
$96.6 |
$103.6 |
6 |
Inhaled Long-acting Beta-adrenoceptor Agonists |
Respiratory conditions |
$63.4 |
$67.4 |
$75.6 |
$73.4 |
7 |
Antifibrinolytics, Haemostatics and Local Sclerosants |
Haemophilia |
$51.3 |
$55.6 |
$58.9 |
$61.3 |
8 |
Multiple Sclerosis Treatments |
Multiple sclerosis |
$33.4 |
$39.4 |
$44.1 |
$49.3 |
9 |
Antivirals |
Hepatitis C |
$135.1 |
$62.6 |
$39.91 |
$48.51 |
10 |
Mucolytics |
Respiratory system and allergies |
$2.4 |
$7.8 |
$14.2 |
$44.7 |
11 |
Antipsychotics |
Mental health |
$35.6 |
$37.3 |
$38.6 |
$40.7 |
12 |
Endocrine Therapy |
HRT |
$41.3 |
$47.9 |
$43.8 |
$40.7 |
13 |
Agents Affecting the Renin-Angiotensin System |
Blood pressure, heart failure, kidney failure, and effects of diabetes |
$15.5 |
$22.1 |
$31.7 |
$38.7 |
14 |
Anticholinergic Agents |
Respiratory conditions |
$28.8 |
$31.4 |
$33.3 |
$34.6 |
15 |
Antiretrovirals |
HIV/AIDS |
$24 |
$26.6 |
$28.2 |
$31.8 |
16 |
Diabetes Management |
Blood glucose monitors and strips |
$25.1 |
$26.7 |
$29.4 |
$31.6 |
17 |
Antiepilepsy Drugs |
Epilepsy |
$26.8 |
$27.2 |
$29.3 |
$31.2 |
18 |
Analgesics |
Pain relief |
$17.4 |
$27.6 |
$26.8 |
$26.8 |
19 |
Oral and Enteral Feeds |
Special food |
$17.9 |
$20.2 |
$23.5 |
$26.0 |
20 |
Stimulants/ADHD Treatments |
ADHD and narcolepsy |
$11.0 |
$11.4 |
$13.4 |
$16.8 |
|
|
Totals |
$1,182.4 |
$1,241.1 |
$1,339.4 |
$1,440.6 |
The data above excludes hospital purchases.
List order has been determined by top spend in the financial year 2021/22.
The gross spend is shown in millions NZD, is exclusive of GST, and prior to the application of rebates and discounts.